AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2018
Oct 2, 2018
29821_dirs_2018-10-02_3175783b-f10b-4316-99be-32f88e488803.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-10-01
Reporting Person: Pierce David A (EVP,Pres MedSurg)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-10-01 | Common Stock | M | 5000.0000 | $7.1600 | Acquired | 29201.0000 | Direct |
| 2018-10-01 | Common Stock | S | 5000.0000 | $38.8020 | Disposed | 24201.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-10-01 | Stock Option (Right to Buy) | $7.1600 | M | 5000.0000 | Disposed | 2021-02-28 | Common Stock (5000.0000) | Direct |
Footnotes
F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: Represents the weighted average sale price. These shares were sold in multiple transactions at $38.7886 and $38.8153. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the grant.